Evidence map›Paper›PMID 40625760›Full record

ArticleInternational cancer conference journal2025

A case of primary malignant melanoma of the ureter.

Masaharu Oki, Kojiro Ohba, Hiroyuki Honda, Shintaro Mori, Shota Kakita, Kyohei Araki, Kensuke Mitsunari, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masaharu OkiDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Kojiro OhbaDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.ORCID 0000-0003-2841-1998
Hiroyuki HondaDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Shintaro MoriDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Shota KakitaDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Kyohei ArakiDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Kensuke MitsunariDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Tomohiro MatsuoDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Yasushi MochizukiDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.
Ryoichi ImamuraDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Sakamoto 1-7-1, Nagasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a laparoscopic left nephroureterectomy for a patient with primary malignant melanoma of the left ureter. Four months after the surgery, bladder metastasis was observed, and the patient underwent radical cystectomy and cutaneous ureterostomy with pelvic lymph node dissection. One month after the surgery, intra-abdominal lymph node metastasis and pelvic seeding appeared, and the patient received three courses of nivolumab, but the disease progressed. The patient died 10 months after the initial diagnosis.

Indexed as

Laparoscopic nephroureterectomyMalignant melanomaRobot-assisted radical cystectomyUreter tumor

Identifiers

PMID40625760
PMCPMC12229410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.